1. Antman K, Shemin R, Ryan L, Klegar K, Osteen R, Herman T, Lederman G, Corson J (1988) Malignant mesothelioma: 19. prognostic variables in a registry of 180 patients, the Dana Farber Cancer Institute and Brigham and Women‘s Hospital experience over two decades, 1965–1985. J Clin Oncol 6:147 –153
2. Ardizzoni A, Hansen H, Dombernowsky P, et al. (1997) 20. Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. J Clin Oncol 15:2090 –2096
3. Bakowski MT, Crouch IC (1983) Chemotherapy for non-small cell lung cancer: a reappraisal and look to the future. Cancer Treat Rep 10: 159–172
4. Becker N, Wahrendorf J (1997) Krebsatlas der Bundesrepublik Deutschland. 3. Aufl., Springer Verlag, Berlin Heidel berg New York
5. Blossom GB, Steiger Z, Stephenson LW (1997) Neoplasms 23. of the mediastinum. In: De Vita V Jr, Hellman S, Rosenberg SA (eds) Cancer - principles and practice of oncology, 5th edn, pp 951– 969, Lippincott-Raven, Philadelphia